{
  "resourceType": "ClinicalUseDefinition",
  "id": "ibrance-dosage",
  "meta": {
    "profile": [
      "http://example.org/fhir/StructureDefinition/EPIDosageClinicalUseDefinition"
    ]
  },
  "type": "indication",
  "subject": [
    {
      "reference": "MedicinalProductDefinition/ibrance-125mg"
    }
  ],
  "indication": {
    "diseaseSymptomProcedure": {
      "coding": [
        {
          "system": "http://snomed.info/sct",
          "code": "254837009",
          "display": "Malignant tumor of breast"
        }
      ]
    }
  },
  "dosage": [
    {
      "sequence": 1,
      "text": "Take one 125 mg tablet orally once daily for 21 days, followed by 7 days off treatment, to complete a 28-day cycle",
      "patientInstruction": "Swallow one 125 mg tablet whole once a day for 21 days with or without food, then stop for 7 days. Repeat every 28 days.",
      "additionalInstruction": [
        {
          "coding": [
            {
              "system": "http://snomed.info/sct",
              "code": "311504000",
              "display": "Swallow whole"
            }
          ]
        },
        {
          "text": "May be taken with or without food"
        }
      ],
      "timing": {
        "repeat": {
          "frequency": 1,
          "period": 1,
          "periodUnit": "d",
          "duration": 21,
          "durationUnit": "d",
          "count": 21
        },
        "boundsPeriod": {
          "start": "2025-06-19",
          "end": "2025-07-16"
        }
      },
      "route": {
        "coding": [
          {
            "system": "http://snomed.info/sct",
            "code": "26643006",
            "display": "Oral"
          }
        ]
      },
      "doseAndRate": [
        {
          "doseQuantity": {
            "value": 1,
            "unit": "tablet",
            "system": "http://snomed.info/sct",
            "code": "428673006"
          }
        }
      ]
    },
    {
      "sequence": 2,
      "text": "Take one 100 mg tablet orally once daily for 21 days, followed by 7 days off treatment, to complete a 28-day cycle, if dose reduction is needed due to adverse reactions",
      "patientInstruction": "Swallow one 100 mg tablet whole once a day for 21 days with or without food, then stop for 7 days. Repeat every 28 days. Use this dose if your doctor reduces it due to side effects like low blood counts.",
      "additionalInstruction": [
        {
          "text": "Use for first dose reduction due to Grade 3 neutropenia with fever ≥38.5°C, Grade 4 neutropenia, or Grade ≥3 non-hematologic toxicity"
        },
        {
          "coding": [
            {
              "system": "http://snomed.info/sct",
              "code": "311504000",
              "display": "Swallow whole"
            }
          ]
        },
        {
          "text": "May be taken with or without food"
        }
      ],
      "timing": {
        "repeat": {
          "frequency": 1,
          "period": 1,
          "periodUnit": "d",
          "duration": 21,
          "durationUnit": "d",
          "count": 21
        },
        "boundsPeriod": {
          "start": "2025-06-19",
          "end": "2025-07-16"
        }
      },
      "route": {
        "coding": [
          {
            "system": "http://snomed.info/sct",
            "code": "26643006",
            "display": "Oral"
          }
        ]
      },
      "doseAndRate": [
        {
          "doseQuantity": {
            "value": 1,
            "unit": "tablet",
            "system": "http://snomed.info/sct",
            "code": "428673006"
          }
        }
      ]
    },
    {
      "sequence": 3,
      "text": "Take one 75 mg tablet orally once daily for 21 days, followed by 7 days off treatment, to complete a 28-day cycle, if further dose reduction is needed or for specific conditions",
      "patientInstruction": "Swallow one 75 mg tablet whole once a day for 21 days with or without food, then stop for 7 days. Repeat every 28 days. Use this dose if your doctor further reduces it due to side effects or if you have severe liver problems or are taking certain other medicines.",
      "additionalInstruction": [
        {
          "text": "Use for second dose reduction due to persistent adverse reactions, or for patients with severe hepatic impairment (Child-Pugh class C), or with concomitant strong CYP3A inhibitors"
        },
        {
          "coding": [
            {
              "system": "http://snomed.info/sct",
              "code": "311504000",
              "display": "Swallow whole"
            }
          ]
        },
        {
          "text": "May be taken with or without food"
        }
      ],
      "timing": {
        "repeat": {
          "frequency": 1,
          "period": 1,
          "periodUnit": "d",
          "duration": 21,
          "durationUnit": "d",
          "count": 21
        },
        "boundsPeriod": {
          "start": "2025-06-19",
          "end": "2025-07-16"
        }
      },
      "route": {
        "coding": [
          {
            "system": "http://snomed.info/sct",
            "code": "26643006",
            "display": "Oral"
          }
        ]
      },
      "doseAndRate": [
        {
          "doseQuantity": {
            "value": 1,
            "unit": "tablet",
            "system": "http://snomed.info/sct",
            "code": "428673006"
          }
        }
      ]
    },
    {
      "sequence": 4,
      "text": "Withhold IBRANCE until recovery to Grade ≤2 for Grade 4 neutropenia, then resume at the next lower dose",
      "patientInstruction": "Stop taking IBRANCE if your doctor detects very low white blood cell counts (Grade 4 neutropenia). Do not take any doses until your doctor confirms your blood counts have improved to a safe level (Grade 2 or better), then resume with a lower dose (100 mg or 75 mg) as directed.",
      "additionalInstruction": [
        {
          "text": "Withhold IBRANCE for Grade 4 neutropenia (CTCAE); monitor complete blood counts weekly until recovery to Grade ≤2, then resume at the next lower dose (100 mg if previously 125 mg, or 75 mg if previously 100 mg)"
        },
        {
          "coding": [
            {
              "system": "http://snomed.info/sct",
              "code": "273870008",
              "display": "Neutropenia"
            }
          ]
        }
      ],
      "timing": {
        "event": [
          {
            "code": {
              "coding": [
                {
                  "system": "http://hl7.org/fhir/v3/ActCode",
                  "code": "HOLD",
                  "display": "Hold"
                }
              ]
            }
          }
        ]
      },
      "asNeededFor": [
        {
          "coding": [
            {
              "system": "http://snomed.info/sct",
              "code": "273870008",
              "display": "Neutropenia"
            }
          ],
          "text": "Grade 4 neutropenia per CTCAE"
        }
      ]
    }
  ]
}